Sex-Specific Regulation of Inflammation and Metabolic Syndrome in Obesity

Supplemental Digital Content is available in the text. Objective: Metabolic dysregulation and inflammation are important consequences of obesity and impact susceptibility to cardiovascular disease. Anti-inflammatory therapy in cardiovascular disease is being developed under the assumption that inflammatory pathways are identical in women and men, but it is not known if this is indeed the case. In this study, we assessed the sex-specific relation between inflammation and metabolic dysregulation in obesity. Approach and Results: Three hundred two individuals were included, half with a BMI 27 to 30 kg/m2 and half with a BMI>30 kg/m2, 45% were women. The presence of metabolic syndrome was assessed according to the National Cholesterol Education Program-ATPIII criteria, and inflammation was studied using circulating markers of inflammation, cell counts, and ex vivo cytokine production capacity of isolated immune cells. Additionally, lipidomic and metabolomic data were gathered, and subcutaneous fat biopsies were histologically assessed. Metabolic syndrome is associated with an increased inflammatory profile that profoundly differs between women and men: women with metabolic syndrome show a lower concentration of the anti-inflammatory adiponectin, whereas men show increased levels of several pro-inflammatory markers such as IL (interleukin)-6 and leptin. Adipose tissue inflammation showed similar sex-specific associations with these markers. Peripheral blood mononuclear cells isolated from men, but not women, with metabolic syndrome display enhanced cytokine production capacity. Conclusions: We identified sex-specific pathways that influence inflammation in obesity. Excessive production of proinflammatory cytokines was observed in men with metabolic syndrome. In contrast, women typically showed reduced levels of the anti-inflammatory adipokine adiponectin. These different mechanisms of inflammatory dysregulation between women and men with obesity argue for sex-specific therapeutic strategies.

[1]  Gennady Korotkevich,et al.  Fast gene set enrichment analysis , 2019, bioRxiv.

[2]  L. Joosten,et al.  Treatment with Statins Does Not Revert Trained Immunity in Patients with Familial Hypercholesterolemia. , 2019, Cell metabolism.

[3]  Yongjae Lee,et al.  Higher monocyte count with normal white blood cell count is positively associated with 10-year cardiovascular disease risk determined by Framingham risk score among community-dwelling Korean individuals , 2019, Medicine.

[4]  L. O’Neill,et al.  A Role for the Krebs Cycle Intermediate Citrate in Metabolic Reprogramming in Innate Immunity and Inflammation , 2018, Front. Immunol..

[5]  C. Newgard,et al.  Metabolomics and Metabolic Diseases: Where Do We Stand? , 2017, Cell metabolism.

[6]  L. Kiemeney,et al.  Cohort Profile Cohort Profile : The Nijmegen Biomedical Study ( NBS ) , 2017 .

[7]  Richard A. Notebaart,et al.  Host and Environmental Factors Influencing Individual Human Cytokine Responses , 2016, Cell.

[8]  R. Xavier,et al.  A Functional Genomics Approach to Understand Variation in Cytokine Production in Humans , 2016, Cell.

[9]  L. Joosten,et al.  Innate immune cell activation and epigenetic remodeling in symptomatic and asymptomatic atherosclerosis in humans in vivo. , 2016, Atherosclerosis.

[10]  L. Joosten,et al.  Oxidized Phospholipids on Lipoprotein(a) Elicit Arterial Wall Inflammation and an Inflammatory Monocyte Response in Humans , 2016, Circulation.

[11]  Richard A. Notebaart,et al.  Understanding human immune function using the resources from the Human Functional Genomics Project , 2016, Nature Medicine.

[12]  Y. Abed,et al.  Obesity and inflammation: the linking mechanism and the complications , 2016, Archives of medical science : AMS.

[13]  T. Assimes,et al.  The glycolytic enzyme PKM2 bridges metabolic and inflammatory dysfunction in coronary artery disease , 2016, The Journal of experimental medicine.

[14]  P. Ridker.  From C-Reactive Protein to Interleukin-6 to Interleukin-1: Moving Upstream To Identify Novel Targets for Atheroprotection. , 2016, Circulation research.

[15]  M. Oosting,et al.  Borrelia-induced cytokine production is mediated by spleen tyrosine kinase (Syk) but is Dectin-1 and Dectin-2 independent. , 2015, Cytokine.

[16]  F. Hu,et al.  The Epidemiology of Obesity: A Big Picture , 2015, PharmacoEconomics.

[17]  Tom R. Gaunt,et al.  Metabolite profiling and cardiovascular event risk: a prospective study of 3 population-based cohorts. , 2015, Circulation.

[18]  Tom R. Gaunt,et al.  Metabolite Profiling and Cardiovascular Event RiskCLINICAL PERSPECTIVE , 2015 .

[19]  M. Blüher,et al.  Adipocyte dysfunction, inflammation and metabolic syndrome , 2014, Reviews in Endocrine and Metabolic Disorders.

[20]  S. Legrand-Poels,et al.  Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes. , 2014, Diabetes research and clinical practice.

[21]  Weijun Luo,et al.  Pathview: an R/Bioconductor package for pathway-based data integration and visualization , 2013, Bioinform..

[22]  Dorothy D. Sears,et al.  Inverse Regulation of Inflammation and Mitochondrial Function in Adipose Tissue Defines Extreme Insulin Sensitivity in Morbidly Obese Patients , 2013, Diabetes.

[23]  P. Libby.  Inflammation in Atherosclerosis , 2012, Arteriosclerosis, thrombosis, and vascular biology.

[24]  M. Stampfer,et al.  Abdominal Superficial Subcutaneous Fat , 2012, Diabetes Care.

[25]  T. Postolache,,et al.  Link between leptin and interleukin-6 levels in the initial phase of obesity related inflammation. , 2012, Translational research : the journal of laboratory and clinical medicine.

[26]  Nicola Zamboni,et al.  High-throughput, accurate mass metabolome profiling of cellular extracts by flow injection-time-of-flight mass spectrometry. , 2011, Analytical chemistry.

[27]  M. den Heijer,et al.  Impact of waist circumference versus adiponectin level on subclinical atherosclerosis , 2009, Journal of internal medicine.

[28]  C. Apovian,et al.  Reduced adipose tissue inflammation represents an intermediate cardiometabolic phenotype in obesity. , 2009, Journal of the American College of Cardiology.

[29]  M. Laakso,et al.  Gender Differences Relating to Metabolic Syndrome and Proinflammation in Finnish Subjects with Elevated Blood Pressure , 2009, Mediators of inflammation.

[30]  J. A. van der Laak,et al.  Peroxisome Proliferator-activated Receptor γ Activation Promotes Infiltration of Alternatively Activated Macrophages into Adipose Tissue* , 2008, Journal of Biological Chemistry.

[31]  T. Wen,et al.  Postprandial hypertriglyceridemia associated with inflammatory response and procoagulant state after a high-fat meal in hypertensive patients , 2008, Coronary artery disease.

[32]  A. La Cava,et al.  Leptin and Inflammation. , 2008, Current immunology reviews.

[33]  Laura Herrero,et al.  Obesity, inflammation, and insulin resistance. , 2007, Gastroenterology.

[34]  R. Paoletti,et al.  Metabolic Syndrome, Inflammation and Atherosclerosis , 2006, Vascular health and risk management.

[35]  Shupei Wang,et al.  Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans Published, JLR Papers in Press, September 8, 2005. DOI 10.1194/jlr.M500294-JLR200 , 2005, Journal of Lipid Research.

[36]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[37]  J. Mckenney,et al.  National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) , 2002 .

[38]  J. Rutledge,et al.  Postprandial Lipemia is Associated With Platelet and Monocyte Activation and Increased Monocyte Cytokine Expression in Normolipemic Men , 2002, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

[39]  L. Groop,et al.  Cardiovascular morbidity and mortality associated with the metabolic syndrome. , 2001, Diabetes care.

[40]  Georgios Kararigas,et al.  Mechanistic Pathways of Sex Differences in Cardiovascular Disease. , 2017, Physiological reviews.

[41]  A. Marjani,et al.  The association between Metabolic Syndrome and serum levels of lipid peroxidation and interleukin-6 in Gorgan. , 2016, Diabetes & metabolic syndrome.

[42]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[43]  S. Gold,et al.  Immune modulation and increased neurotrophic factor production in multiple sclerosis patients treated with testosterone , 2008, Journal of Neuroinflammation.

[44]  S. Grundy,et al.  National Cholesterol Education Program Third Report of the National Cholesterol Education Program ( NCEP ) Expert Panel on Detection , Evaluation , and Treatment of High Blood Cholesterol in Adults ( Adult Treatment Panel III ) Final Report , 2022 .

[45]  Susumu Goto,et al.  KEGG: Kyoto Encyclopedia of Genes and Genomes , 2000, Nucleic Acids Res..

[46]  Hiroyuki Ogata,et al.  KEGG: Kyoto Encyclopedia of Genes and Genomes , 1999, Nucleic Acids Res..

[47]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .